ArticleFEBS open bio2024

Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT.

Lingkai Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.